A comparative analysis of outpatient costs in HIV treatment programs

OBJECTIVE: To analyze the costs of human immunodeficiency virus (HIV) outpatient treatment for individuals with different CD4 cell counts in the Brazilian public health system, and to compare to costs in other national health systems. METHODS: A retrospective survey was conducted in five public outpatient clinics of the Brazilian national HIV program in the city of São Paulo. Data on healthcare services provided for a period of one year of HIV outpatient treatment were gathered from randomly selected medical records. Prices of inputs used were obtained through market research and public sector databases. Information on costs of HIV outpatient treatment in other national health systems were gathered from the literature. Annual costs of HIV outpatient treatment from each country were converted into 2010 U.S. dollars. RESULTS: Annual cost of HIV outpatient treatment for the Brazilian national public program was US$ 2,572.92 in 2006 in São Paulo, ranging from US$ 1,726.19 for patients with CD4 cell count > 500 to US$ 3,693.28 for patients with 51 < CD4 cell count < 200. Antiretrovirals (ARVs) represented approximately 62.0% of annual HIV outpatient costs. Comparing among different health systems during the same period, HIV outpatient treatment presented higher costs in countries where HIV treatment is provided by the private sector. CONCLUSION: The main cost drivers of HIV outpatient treatment in different health systems were: ARVs, other medications, health professional services, and diagnostic exams. Nevertheless, the magnitude of cost drivers varied among HIV outpatient treatment programs due to health system efficiency. The data presented may be a valuable tool for public policy evaluation of HIV treatment programs worldwide.

Avaliação comparativa entre custos dos processos MBBR/IFAS e lodo ativado para o tratamento de esgoto sanitário

O processo MBBR/IFAS, Moving Bed Biofilm Reactor/Integrated Fixed Film Activated Sludge, é uma tecnologia recente para o tratamento de esgoto que incorpora tanto biomassa em suspensão como aderida. Seus parâmetros de controle são os mesmos aplicados ao processo de lodo ativado, observadas algumas especificidades. Como objetivo principal deste trabalho, apresenta-se uma análise comparativa entre os custos de implantação de uma unidade IFAS e de lodo ativado operando sob alta taxa, na faixa convencional e com aeração prolongada, para populações de 50.000 e 500.000 habitantes. Os resultados mostraram que, sob as hipóteses assumidas para a implantação dos reatores, o custo do processo de lodo ativado foi de 36% até 100% do custo do processo IFAS, dependendo da carga orgânica aplicada, do preço do terreno ou do custo do meio suporte.